{"id":157010,"date":"2022-06-07T21:10:28","date_gmt":"2022-06-07T18:10:28","guid":{"rendered":"https:\/\/www.enerjigazetesi.ist\/?p=157010"},"modified":"2022-06-07T21:19:19","modified_gmt":"2022-06-07T18:19:19","slug":"losev-den-dunya-capinda-bir-kanser-sempozyumu","status":"publish","type":"post","link":"https:\/\/www.enerjigazetesi.ist\/en\/losev-den-dunya-capinda-bir-kanser-sempozyumu\/","title":{"rendered":"(Turkish) ’L\u00f6sev’den D\u00fcnya \u00c7ap\u0131nda Bir Kanser Sempozyumu"},"content":{"rendered":"

Sorry, this entry is only available in Turkish<\/a>. For the sake of viewer convenience, the content is shown below in the alternative language. You may click the link to switch the active language.<\/p>

<\/p>\n

L\u00d6SEV ge\u00e7en hafta sonu Ankara\u2019da d\u00fcnya \u00e7ap\u0131nda bir kanser sempozyumu ger\u00e7ekle\u015ftirdi. Farkl\u0131 \u00fclkelerden onkoloji ve hematoloji alan\u0131nda uzman bilim insanlar\u0131, \u201c\u0130mm\u00fcnoterapinin kemoterapinin yerini al\u0131r demek hen\u00fcz erken. K\u00f6r erkeklerin ve gece vardiyas\u0131nda \u00e7al\u0131\u015fan kad\u0131nlar\u0131n kansere yakalanma oranlar\u0131nda art\u0131\u015f g\u00f6r\u00fclmesine dair \u00e7al\u0131\u015fmalara devam ediliyor.\u201d <\/em>\u015feklinde g\u00fcncel \u00e7al\u0131\u015fmalardan bahsederken, 2. D\u00fcnya Sava\u015f\u0131 verileriyle Japonya\u2019dan ABD\u2019ye g\u00f6\u00e7 ve artan kanser vakalar\u0131 ile \u2018bat\u0131ya g\u00f6\u00e7le kanserde paralel art\u0131\u015f\u0131 tespit ettiklerinin alt\u0131n\u0131 \u00e7izdi.<\/strong><\/h2>\n

L\u00d6SEV<\/strong> L\u00f6semili \u00c7ocuklar Sa\u011fl\u0131k ve E\u011fitim Vakf\u0131,Uluslararas\u0131 L\u00f6semili \u00c7ocuklar Ay\u0131<\/em> kapsam\u0131nda ge\u00e7ti\u011fimiz hafta sonu Ankara\u2019da \u00f6nemli bir toplant\u0131ya ev sahipli\u011fi yapt\u0131. D\u00fcnyada kanser \u00e7al\u0131\u015fmalar\u0131na \"\"hizmet veren \u00f6nemli bilim insanlar\u0131, 1’incisi<\/strong> d\u00fczenlenen L\u00d6SANTE \u2013 L\u00d6SEV 1. Uluslararas\u0131 Kanser ve Hayat Sempozyumu\u2019yla,<\/strong> L\u00d6SANTE Hastanesi\u2019nde bir araya geldi. <\/strong>\u0130lk g\u00fcn ger\u00e7ekle\u015fen oturumlarda sa\u011fl\u0131k profesyonelleri a\u011f\u0131rlanarak l\u00f6semi, kanser, sa\u011fl\u0131kl\u0131 beslenme<\/strong> ve kansere yol a\u00e7an etmenler<\/strong> konu\u015fuldu. L\u00f6semi<\/strong> ve kanser tedavisi s\u00fcre\u00e7leri, geli\u015fen teknolojilerle<\/strong> ve erken te\u015fhislerle<\/strong> tedavi imk\u00e2nlar\u0131, moral<\/strong> ve motivasyonu y\u00fcksek<\/strong> tutman\u0131n kanserle sava\u015fmada \u00f6nemi gibi konular\u0131n \u00fczerinde duruldu. 2’inci g\u00fcn<\/strong> ise iyile\u015fen kanser hastalar\u0131, hasta yak\u0131nlar\u0131<\/strong> ve g\u00f6n\u00fcll\u00fcler<\/strong> kat\u0131ld\u0131. Sempozyuma Milano-Bicocca \u00dcniversitesi\u2019<\/strong>nden Prof. Andrea Biondi, Duisburg-Essen \u00dcniversitesi\u2019nden Prof. Dirk Reinhardt, Wageningen \u00dcniversitesi\u2019nden Prof. Ellen Kampman, Yale \u00dcniversitesi\u2019nden Anees Chagpargibi<\/em> onkoloji, pediatri ve beslenme alan\u0131nda uzmanlar kat\u0131ld\u0131.<\/p>\n

\u201c\u0130mm\u00fcnoterapi kemoterapinin yerini al\u0131r demek i\u00e7in erken\u201d<\/strong><\/h3>\n

Prof. Biondi yapt\u0131\u011f\u0131 konu\u015fmas\u0131nda kanser tedavilerinde y\u00fcksek gelirli ve d\u00fc\u015f\u00fck gelirli \u00fclkelerdeki ya\u015fanan farkl\u0131l\u0131klara de\u011finerek tedavi ile birlikte desteklenmesi gereken ba\u015fl\u0131klara da vurgu yapt\u0131. Kendisine y\u00f6neltilen imm\u00fcnoterapi<\/strong> ileride klasik kemoterapi<\/strong> gibi konvansiyonel terapinin yerini al\u0131r m\u0131 sorusuna kar\u015f\u0131l\u0131k \u015funlar\u0131 kaydetti, \u201c\u00c7ok iyi sonu\u00e7lar ald\u0131k ama tamamen yerini almayacak. Bunun yerine ba\u015fka bir \u015fey ge\u00e7mesi i\u00e7in \u00e7ok erken. Belirli ad\u0131mlar var. Bir k\u0131s\u0131m zorluklar\u0131 elimine edebiliyoruz. \u00d6zellikle yeti\u015fkinlerde \u00e7ok iyi sonu\u00e7lar ald\u0131k. Bunlar tedavinin bir par\u00e7as\u0131 olacak imm\u00fcno terapilerle de<\/strong> \u00e7ok iyi geli\u015fecek.\u201d<\/em><\/p>\n

Hayat ritmi de\u011fi\u015fince kanser art\u0131yor mu?<\/strong><\/h3>\n

Beslenme<\/strong> ve ya\u015fam tarz\u0131n\u0131n<\/strong> kanserle ili\u015fkili ba\u011f\u0131 hakk\u0131nda anekdotlar\u0131 payla\u015f\u0131rken pestisite maruz kalman\u0131n etkisini vurgulayan Prof. Kampman ise \u015fu payla\u015f\u0131mlarda bulundu, \u201cT\u00fcm d\u00fcnyada kanser t\u0131rmanmakta<\/strong>. T\u00fcrkiye ile ilgili durum ne diye bakt\u0131\u011f\u0131m\u0131zda hala akci\u011fer kanseri, meme kanseri<\/strong> en fazla g\u00f6r\u00fclen kanser \u00e7e\u015fitleri. 2’inci d\u00fcnya sava\u015f\u0131ndan<\/strong> sonra Japonlar \u00e7ok klasik ya\u015fam tarzlar\u0131n\u0131 ABD\u2019ye ge\u00e7ince koruyamad\u0131. G\u00f6\u00e7 ile paralel mide kanseri<\/strong> de artt\u0131. \u00c7ok h\u0131zl\u0131 bir \u015fekilde 1- 2 jenerasyon<\/strong> i\u00e7inde kanser art\u0131\u015f\u0131 g\u00f6zlendi. Genler bu kadar h\u0131zl\u0131 de\u011fi\u015fmiyor ba\u015fka bir \u015fey de\u011fi\u015fti o zaman. Pek \u00e7ok ki\u015finin kayg\u0131s\u0131 var ve kanser t\u00fcm d\u00fcnyada art\u0131yor. Kentle\u015fme<\/strong> ve bat\u0131 tarz\u0131 hayat<\/strong> ya\u015famakla paralel diyebiliriz.\u201d Di\u011fer yandan kendisine y\u00f6nlendirilen gece vardiyas\u0131nda \u00e7al\u0131\u015fan kad\u0131nlarda ve k\u00f6r erkeklerde kanserin g\u00f6r\u00fclme s\u0131kl\u0131kl\u0131\u011f\u0131 ile ilgili soruya ili\u015fkin \u201cHayat ritmi de\u011fi\u015fiyor uyku d\u00fczeni de de\u011fi\u015fiyor ve yine normal ritminizin d\u0131\u015f\u0131na \u00e7\u0131kt\u0131\u011f\u0131n\u0131zda kanser art\u0131yor mu bunlarla ilgili \u00e7ok \u00e7al\u0131\u015fma devam ediyor. Bu sorunun cevab\u0131n\u0131 netle\u015ftirmek \u00fczere \u00e7abal\u0131yoruz.\u201d<\/em><\/p>\n

L\u00d6SEV & L\u00d6SANTE Kurucu Y\u00f6netim Kurulu Ba\u015fkan\u0131<\/em> Pediatrik Hematolog Onkolog<\/em> Dr. \u00dcst\u00fcn EZER<\/strong>, yapt\u0131\u011f\u0131 a\u00e7\u0131l\u0131\u015f konu\u015fmas\u0131nda \u015funlar\u0131 kaydetti, \u201c90’l\u0131 y\u0131llarda<\/strong> Pediatri hematoloji lisans\u0131m\u0131<\/strong> yapt\u0131ktan sonra mesle\u011fime ba\u015flad\u0131\u011f\u0131mda hemen hemen \u00e7o\u011fu \u00e7ocu\u011fumuzu kaybediyorduk. Bu kay\u0131plar\u0131n alt\u0131ndaki en b\u00fcy\u00fck sebepler enfeksiyon, maddi s\u0131k\u0131nt\u0131lar, a\u00e7l\u0131k <\/strong>ve yokluktu<\/strong>. Bu y\u0131llarda en iyi ihtimalle %20<\/strong>‘lerde olan tedavi ba\u015far\u0131 oran\u0131 bizi bir yol ayr\u0131m\u0131na<\/strong> g\u00f6t\u00fcrm\u00fc\u015ft\u00fc. 1998 y\u0131l\u0131nda arkada\u015flar\u0131mla<\/strong> birlikte L\u00d6SEV<\/strong>\u2019i ve b\u00fcy\u00fck bir \u00e7aba sarf ettik. Biz L\u00d6SEV\u2019i kurdu\u011fumuzda herkes dalga ge\u00e7ti. \u2018L\u00f6semi tedavi edilebilen bir hastal\u0131kt\u0131r\u2019<\/strong> diyorduk herkes bana para toplamak i\u00e7in halk\u0131 kand\u0131r\u0131yor diyorlard\u0131. O g\u00fcnden bug\u00fcne %92 + 2<\/strong> ba\u015far\u0131ya geldik. Hem bilimsel<\/strong> hem fiziksel yap\u0131<\/strong> ve etki alan\u0131ndaki \u00e7abalar\u0131m\u0131zla L\u00d6SEV<\/strong> olarak tek bir \u00e7ocu\u011fumuzu dahi kaybetmeyene kadar \u00e7al\u0131\u015fmalar\u0131m\u0131z daha g\u00fc\u00e7l\u00fc devam edecektir.\u201d<\/em><\/p>","protected":false},"excerpt":{"rendered":"

Sorry, this entry is only available in Turkish. For the sake of viewer convenience, the content is shown below in the alternative language. You may click the link to switch the active language. L\u00d6SEV ge\u00e7en hafta sonu Ankara\u2019da d\u00fcnya \u00e7ap\u0131nda bir kanser sempozyumu ger\u00e7ekle\u015ftirdi. Farkl\u0131 \u00fclkelerden onkoloji ve hematoloji alan\u0131nda uzman bilim insanlar\u0131, \u201c\u0130mm\u00fcnoterapinin kemoterapinin […]<\/p>\n","protected":false},"author":1,"featured_media":157013,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[53,4],"tags":[85750,103832,24852,103834,103833,103829,103830,86460,38780,103831,80022],"views":102,"_links":{"self":[{"href":"https:\/\/www.enerjigazetesi.ist\/en\/wp-json\/wp\/v2\/posts\/157010"}],"collection":[{"href":"https:\/\/www.enerjigazetesi.ist\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.enerjigazetesi.ist\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.enerjigazetesi.ist\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.enerjigazetesi.ist\/en\/wp-json\/wp\/v2\/comments?post=157010"}],"version-history":[{"count":0,"href":"https:\/\/www.enerjigazetesi.ist\/en\/wp-json\/wp\/v2\/posts\/157010\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.enerjigazetesi.ist\/en\/wp-json\/wp\/v2\/media\/157013"}],"wp:attachment":[{"href":"https:\/\/www.enerjigazetesi.ist\/en\/wp-json\/wp\/v2\/media?parent=157010"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.enerjigazetesi.ist\/en\/wp-json\/wp\/v2\/categories?post=157010"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.enerjigazetesi.ist\/en\/wp-json\/wp\/v2\/tags?post=157010"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}